Fluro-Gold: composition, and mechanism of uptake

Determining the mechanism by which fluorescent retrograde neuronal tracers are taken up requires knowledge of their composition. It has been claimed that Fluoro-Gold, a retrogradely transported fluorescent neuronal tracer, is 2-hydroxy-4,4'-diamidinostilbene (hydroxystilbamidine), an amidine antibiotic. However, this appears questionable, since the fluorescence spectrograms reported for Fluoro-Gold differ markedly from the spectrograms previously reported for purified hydroxystilbamidine. To help clarify the mechanism by which Fluoro-Gold might be taken up, it was decided to examine its composition and determine whether hydroxystilbamidine was its active agent. Fluoro-Gold was found by mass spectrometry to contain a component with a molecular weight of 280 Da (identical to that of hydroxystilbamidine), and fluorescence spectroscopy demonstrated the existence of a substance with a fluorescence spectrum similar to that of purified hydroxystilbamidine. Although a major fluorescent impurity was also observed, chromatographic separation of different fluorescent components of Fluoro-Gold suggested that the fraction resembling hydroxystilbamidine was responsible for its retrograde labeling of cells. It is concluded that hydroxystilbamidine is the active constituent of Fluoro-Gold. Chemically, hydroxystilbamidine is a weak base. In this respect it resembles True blue, DAPI, Granular blue, bis-benzimide, Nuclear yellow, and several other retrogradely transported molecules. It is suggested that these agents cross cell membranes in their uncharged form and are trapped in lysosomes and endosomes by a favorable pH gradient. Thus, the uptake of this type of retrograde tracer may be an example of a well-understood process occurring widely throughout biological systems: the trapping of weak bases in acidic cellular compartments.

[1]  I. Snapper Influence of 2-hydroxystilbamidine on the course of multiple myeloma. , 1948, Journal of the Mount Sinai Hospital, New York.

[2]  L. Swanson,et al.  SITS: a covalently bound fluorescent retrograde tracer that does not appear to be taken up by fibers-of-passage , 1982, Brain Research.

[3]  L. Schmued,et al.  Neurons containing retrogradely transported Fluoro-Gold exhibit a variety of lysosomal profiles: A combined brightfield, fluorescence, and electron microscopic study , 1989, Journal of neurocytology.

[4]  W. Yorke,et al.  Studies in Chemotherapy: XXX.—The Trypanocidal Action of Additional Aromatic Diamidines , 1942 .

[5]  A. Allison,et al.  UPTAKE OF DYES AND DRUGS BY LIVING CELLS IN CULTURE. , 1964, Life sciences.

[6]  M. J. Ehrke,et al.  Studies on the structure--activity relationship among aliphatic and aromatic bisguanylhydrazones and some related compounds. , 1977, Chemico-biological interactions.

[7]  A. Barber EXPENDITURE ON N.H.S. PRACTICE PREMISES. THE MINISTER'S LETTER. , 1964, Lancet.

[8]  D. Webb,et al.  Photoluminescence of solutions , 1969 .

[9]  K. D. Cliffer,et al.  Evidence that Fluoro-Gold can be transported avidly through fibers of passage , 1990, Brain Research.

[10]  B. Festy,et al.  Hydroxystilbamidine. A nonintercalating drug as a probe of nucleic acid conformation. , 1973, Biochemistry.

[11]  B. Festy,et al.  Interaction between hydroxystilbamidine and DNA. I. Binding isotherms and thermodynamics of the association. , 1975, Biochimica et biophysica acta.

[12]  G. Odom,et al.  Stilbamidine isethionate therapy of tic douloureux. , 1955, Journal of neurosurgery.

[13]  H. Kuypers,et al.  Two new fluorescent retrograde neuronal tracers which are transported over long distances , 1980, Neuroscience Letters.

[14]  E. Delain,et al.  Ultrastructural alterations of Trypanosoma cruzi kinetoplast induced by the interaction of a trypanocidal drug (hydroxystilbamidine) with the kinetoplast DNA. , 1971, Journal of ultrastructure research.

[15]  H. Kuypers,et al.  Retrograde anoxal transport of fluorescent substances in the rat's forebrain , 1977, Neuroscience Letters.

[16]  C. Patton,et al.  Pentamidine transport in Trypanosoma brucei-kinetics and specificity. , 1976, Biochemical pharmacology.

[17]  M. Stefanini,et al.  Fixation of Ejaculated Spermatozoa for Electron Microscopy , 1967, Nature.

[18]  J. Hobson,et al.  North American blastomycosis: clinical forms of the disease and treatment with stilbamidine and 2-hydroxystilbamidine. , 1954, Annals of internal medicine.

[19]  E. Greenspan,et al.  Determination of stilbamidine and 2‐hydroxystilbamidine deposited in parenchymatous organs and tumors , 1951, Cancer.

[20]  G. B. Proctor,et al.  Variation between different samples of sits with respect to axonal transport and toxicity , 1983, Neuroscience Letters.

[21]  E. Greenspan,et al.  Influence of nucleic acid upon the fluorescence of nuclei and cytoplasm after injection of aromatic diamidines. , 1951, The Journal of laboratory and clinical medicine.

[22]  J. Folds,et al.  Immunosuppression by hydroxystilbamidine isethionate, a lysosome-stabilizing, anti-proteolytic, antifungal drug , 1975, Infection and immunity.

[23]  J. F. Sotos,et al.  Determination of intramitochondrial pH and intramitochondrial-extramitochondrial pH gradient of isolated heart mitochondria by the use of 5,5-dimethyl-2,4-oxazolidinedione. I. Changes during respiration and adenosine triphosphate-dependent transport of Ca++, Mg++, and Zn++. , 1968, The Journal of biological chemistry.

[24]  H. Kuypers,et al.  Retrograde transport of bisbenzimide and propidium iodide through axons to their parent cell bodies , 1979, Neuroscience Letters.

[25]  M. G. Honig,et al.  Dil and DiO: versatile fluorescent dyes for neuronal labelling and pathway tracing , 1989, Trends in Neurosciences.

[26]  J. Fulton The Therapeutic Action of Some Newer Aromatic Diamidines on Leishmania Donovani Infections of Golden Hamsters (Cricetus Auratus) , 1944 .

[27]  L. Borges Selective axonal transport of anthracycline antibiotics , 1987, Brain Research.

[28]  B Poole,et al.  Cytoplasmic vacuolation of mouse peritoneal macrophages and the uptake into lysosomes of weakly basic substances , 1981, The Journal of cell biology.

[29]  R. Zana,et al.  Interaction between hydroxystilbamidine and DNA. II. Temperature jump relaxation study. Dynamics of nucleic acids and polynucleotides. , 1975, Biochimica et biophysica acta.

[30]  G. Rudnick Acidification of Intracellular Organelles , 1987 .

[31]  J. O. Harris,et al.  112. Attempts to find new chemotherapeutic amidines. Part III. Nuclear substituted derivatives of 4 : 4′- and 3 : 3′-diamidinostilbene , 1946 .

[32]  L. Schmued,et al.  Fluoro-gold: a new fluorescent retrograde axonal tracer with numerous unique properties , 1986, Brain Research.

[33]  H. Kuypers,et al.  Fluorescent retrograde neuronal labeling in rat by means of substances binding specifically to adeninethymine rich DNA , 1979, Neuroscience Letters.

[34]  M. Slavik,et al.  Chromomycin A3, mithramycin, and olivomycin: antitumor antibiotics of related structure. , 1975, Advances in pharmacology and chemotherapy.

[35]  G. Weissmann,et al.  Studies on lysosomes. 13. Effects of stilbamidine and hydroxystilbamidine on in vitro and in vivo systems. , 1970, Biochemical pharmacology.

[36]  L. Schmued,et al.  Fluoro-Gold and 4-Acetamido-4′-isothiocyanostilbene-2,2′-disulfonic Acid: Use of Substituted Stilbenes in Neuroanatomical Studies , 1990 .

[37]  P. Lizardi Isolation of giant silk fibroin polysomes and fibroin mRNP particles using a novel ribonuclease inhibitor, hydroxystilbamidine , 1980, The Journal of cell biology.

[38]  J. Shaw,et al.  A STUDY OF GRANULES AND OTHER CHANGES IN PHASE-CONTRAST APPEARANCE PRODUCED BY CHEMOTHERAPEUTIC AGENTS IN TRYPANOSOMES. , 1963, British journal of pharmacology and chemotherapy.

[39]  D. D. Perrin Dissociation Constants of Organic Bases in Aqueous Solution , 1965 .

[40]  J. Lakowicz Principles of fluorescence spectroscopy , 1983 .

[41]  J. Hampton The excretion of stilbamidine and some related compounds in experimental animals. , 1947, Annals of tropical medicine and parasitology.

[42]  C. Hughes,et al.  Antifungal agents used for deep-seated mycotic infections. , 1987, Mayo Clinic proceedings.

[43]  S. Ohkuma,et al.  Effect of weak bases on the intralysosomal pH in mouse peritoneal macrophages , 1981, The Journal of cell biology.

[44]  E. Mihich,et al.  Antileukemic action of new aromatic bisguanylhydrazone derivatives , 1967, Cancer.

[45]  P. Tulkens,et al.  Commentary. Lysosomotropic agents. , 1974, Biochemical pharmacology.

[46]  J. Utz Chemotherapy for the systemic mycoses: the prelude to ketoconazole. , 1980, Reviews of infectious diseases.

[47]  P. Collard,et al.  Neuropathy after stilbamidine; treatment of kala-azar. , 1947, Lancet.